Chronic Thromboembolic Pulmonary Hypertension

Area of Science:

• Cardiology
• Pulmonology
• Vascular Surgery

Background:

• Chronic thromboembolic pulmonary hypertension (CTEPH) is more common than recognized, often leading to misdiagnosis and severe symptoms.
• The condition involves pathologic arterial changes from chronic pulmonary embolism, carrying a poor prognosis and high mortality rate.
• Current medical therapies offer only transient symptom relief and do not alter the disease's prognosis.

Purpose of the Study:

• To highlight the prevalence and diagnostic challenges of CTEPH.
• To emphasize the limitations of medical management for CTEPH.
• To advocate for pulmonary endarterectomy as the most effective therapeutic option.

Main Methods:

• Review of the pathophysiology and clinical presentation of CTEPH.
• Analysis of the efficacy and outcomes of medical management.
• Evaluation of surgical interventions, specifically pulmonary endarterectomy, compared to pulmonary transplantation.

Main Results:

• Pulmonary endarterectomy demonstrates significant advantages over pulmonary transplantation, including lower operative mortality and no need for chronic immunosuppression.
• Despite advancements, the mortality rate for pulmonary endarterectomy at some institutions ranges from 5% to 7%, even in high-risk patients.
• Underrecognition of CTEPH remains a major obstacle to timely and effective treatment.

Conclusions:

• Pulmonary endarterectomy is the most appropriate and effective treatment for CTEPH, offering excellent long-term results and clinical improvement.
• Increased awareness of CTEPH and its surgical treatment is crucial for improving patient outcomes.
• Early diagnosis and surgical intervention can relieve symptoms and improve the prognosis for patients with CTEPH.